Skip to main content
OpenTrials

Clinical trial condition

B-Cell Non-Hodgkins Lymphoma

Explore clinical trials studying B-Cell Non-Hodgkins Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study
Refine in advanced search Browse all conditions

B-Cell Non-Hodgkins Lymphoma trial results

Recruiting

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

NCT06806033

Conditions
B-Cell Non-Hodgkins Lymphoma, Cytokine Release Syndrome, Disease Attributes, +17 more
Locations
  • Alaska Oncology & Hematology, LLC Anchorage, Alaska, United States
  • Community Cancer Institute (CCI) Clovis, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
View all 53 locations
View Trial Details
Completed

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

NCT02924402

Conditions
B-Cell Non-Hodgkins Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +50 more
Locations
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Northside Hospital Atlanta, Georgia, United States
  • The University of Chicago Medicine Chicago, Illinois, United States
View all 23 locations
View Trial Details

Related conditions